SCHEMBL5334381

SCHEMBL5334381

CS(=O)(=O)N1CCc2ccccc2CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
ALDH1A1 P00352 2/20 0.50
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
DRD4 P21917 1/20 0.48
DRD5 P21918 1/20 0.48
DRD3 P35462 1/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2103706 0.90 KMT2A (0.64) KMT2AMEN1ESR1ESR2L3MBTL1
SCHEMBL29325467 0.79 ESR1 (0.48) KMT2AMEN1ALDH1A1ESR1ESR2
SCHEMBL30721536 0.79 ESR1 (0.55) KMT2AMEN1ESR1ESR2L3MBTL1
SCHEMBL30721539 0.79 ESR1 (0.55) KMT2AMEN1ESR1ESR2L3MBTL1
SCHEMBL2060640 0.77 ESR2 (0.54) ESR1ESR2L3MBTL1CYP2D6HRH3
SCHEMBL1266336 0.77 ESR1 (0.49) KMT2AMEN1ALDH1A1ESR1ESR2
SCHEMBL17227611 0.76 KMT2A (0.62) KMT2AMEN1L3MBTL1SMN1; SMN2MAOA
SCHEMBL31629349 0.76 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL29325471 0.76 GRIN1 (0.50) ALDH1A1ESR1ESR2CYP1A2CYP3A4
SCHEMBL3007964 0.75 KMT2A (0.66) KMT2AMEN1L3MBTL1SMN1; SMN2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833473-A2 5HT2C RECEPTOR MODULATOR COMPOSITIONS AND METHODS OF USE Arena Pharmaceuticals, Inc. (US) 2007-09-19 EP claimed
WO-2006071740-A2 5HT2C RECEPTOR MODULATOR COMPOSITIONS AND METHODS OF USE ARENA PHARMACEUTICALS, INC. (US) 2006-07-06 WO claimed